Celcuity (CELC) Other Non-Current Assets (2017 - 2026)

Celcuity's (CELC) quarterly Other Non-Current Assets came in at $349000.0 in Q4 2025, up 598.0% on a QoQ basis from $50000.0 in Q2 2018.

Analysis

Celcuity (CELC) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Celcuity (CELC) has 3 years of Other Non-Current Assets data on file, last reported at $349000.0 in Q4 2025.

Quarterly Other Non-Current Assets changed N/A year-over-year to $349000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $349000.0 (changed N/A YoY) and the FY2025 annual result came in at $349000.0, changed N/A from the prior year.
Other Non-Current Assets grew to $349000.0 in Q4 2025, from $50000.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $349000.0 in Q4 2025 to a low of $349000.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	618.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	42.45 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	109.58 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	65.13 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	62.96 Mn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	104.44 Mn
10	Celcuity	5.25 Bn	5.25 Bn	-	661,000.00

Historic Data

Download Data